Barclays Sticks to Their Sell Rating for WW International (WW)

In a report released today, Stephanie Davis from Barclays maintained a Sell rating on WW International (WW – Research Report), with a price target of $1.50. The company’s shares closed yesterday at $1.89.

Davis covers the Healthcare sector, focusing on stocks such as Healthequity, Laboratory, and OptimizeRx. According to TipRanks, Davis has an average return of -7.0% and a 39.40% success rate on recommended stocks.

Currently, the analyst consensus on WW International is a Moderate Buy with an average price target of $5.75.

Based on WW International’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $214.87 million and a net profit of $43.73 million. In comparison, last year the company earned a revenue of $249.72 million and had a GAAP net loss of $206.04 million

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

WW International (WW) Company Description:

WW International, Inc. engages in the provision of weight management services. It operates through the following geographical segments: North America, United Kingdom, Continental Europe and Other. The North America segment consists of United States and Canada Company-owned operations. The United Kingdom segment includes United Kingdom Company-owned operations. The Continental Europe segment comprises of Germany, Switzerland, France, Spain, Belgium, Netherlands, and Sweden Company-owned operations. The others segment offers Australia, New Zealand, Mexico, and Brazil Company-owned operations, as well as revenues and costs from franchises in the United States. The company was founded by Jean Nidetch in 1963 and is headquartered in New York, NY.